Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey C Nguyen

Showing results (191-200 of 229) with videos related to

Pageof 23
Sort By:
Journal of the Canadian Association of Gastroenterology|July 12, 2019
The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services UtilizationM Ellen Kuenzig, Eric I Benchimol, Lawrence Lee, et al.
Canadian Journal of Gastroenterology & Hepatology|May 20, 2014
Defining quality indicators for best-practice management of inflammatory bowel disease in CanadaGeoffrey C Nguyen, Shane M Devlin, Waqqas Afif, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 8, 2019
Primary Sclerosing Cholangitis in Children With Inflammatory Bowel Diseases Is Associated With Milder Clinical Activity But More Frequent Subclinical Inflammation and Growth ImpairmentAmanda Ricciuto, Bettina E Hansen, Brian Ngo, et al.
Gastrointestinal Endoscopy|March 11, 2015
Gastrointestinal Endoscopy Competency Assessment Tool: reliability and validity evidenceCatharine M Walsh, Simon C Ling, Nitin Khanna, et al.
Journal of the Canadian Association of Gastroenterology|July 12, 2019
The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD CareM Ellen Kuenzig, Lawrence Lee, Wael El-Matary, et al.
Inflammatory Bowel Diseases|September 9, 2016
Preoperative Anti-tumor Necrosis Factor Therapy in Patients with Ulcerative Colitis Is Not Associated with an Increased Risk of Infectious and Noninfectious Complications After Ileal Pouch-anal AnastomosisEran Zittan, Raquel Milgrom, Grace W Ma, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 19, 2018
Upfront Combination Therapy, Compared With Monotherapy, for Patients Not Previously Treated With a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort StudyLaura E Targownik, Eric I Benchimol, Charles N Bernstein, et al.
Gastroenterology|January 28, 2014
Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of GastroenterologyGeoffrey C Nguyen, Charles N Bernstein, Alain Bitton, et al.
Journal of Crohn'S & Colitis|July 11, 2020
Combined Biologic and Immunomodulatory Therapy is Superior to Monotherapy for Decreasing the Risk of Inflammatory Bowel Disease-Related ComplicationsLaura E Targownik, Eric I Benchimol, Charles N Bernstein, et al.
Journal of the Canadian Association of Gastroenterology|July 12, 2019
The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBDMatthew W Carroll, M Ellen Kuenzig, David R Mack, et al.
Pageof 23

Showing results (191-200 of 229) with videos related to

Sort By:
Pageof 23
Journal of the Canadian Association of Gastroenterology|July 12, 2019
The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services UtilizationM Ellen Kuenzig, Eric I Benchimol, Lawrence Lee, et al.
Canadian Journal of Gastroenterology & Hepatology|May 20, 2014
Defining quality indicators for best-practice management of inflammatory bowel disease in CanadaGeoffrey C Nguyen, Shane M Devlin, Waqqas Afif, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 8, 2019
Primary Sclerosing Cholangitis in Children With Inflammatory Bowel Diseases Is Associated With Milder Clinical Activity But More Frequent Subclinical Inflammation and Growth ImpairmentAmanda Ricciuto, Bettina E Hansen, Brian Ngo, et al.
Gastrointestinal Endoscopy|March 11, 2015
Gastrointestinal Endoscopy Competency Assessment Tool: reliability and validity evidenceCatharine M Walsh, Simon C Ling, Nitin Khanna, et al.
Journal of the Canadian Association of Gastroenterology|July 12, 2019
The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD CareM Ellen Kuenzig, Lawrence Lee, Wael El-Matary, et al.
Inflammatory Bowel Diseases|September 9, 2016
Preoperative Anti-tumor Necrosis Factor Therapy in Patients with Ulcerative Colitis Is Not Associated with an Increased Risk of Infectious and Noninfectious Complications After Ileal Pouch-anal AnastomosisEran Zittan, Raquel Milgrom, Grace W Ma, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 19, 2018
Upfront Combination Therapy, Compared With Monotherapy, for Patients Not Previously Treated With a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort StudyLaura E Targownik, Eric I Benchimol, Charles N Bernstein, et al.
Gastroenterology|January 28, 2014
Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of GastroenterologyGeoffrey C Nguyen, Charles N Bernstein, Alain Bitton, et al.
Journal of Crohn'S & Colitis|July 11, 2020
Combined Biologic and Immunomodulatory Therapy is Superior to Monotherapy for Decreasing the Risk of Inflammatory Bowel Disease-Related ComplicationsLaura E Targownik, Eric I Benchimol, Charles N Bernstein, et al.
Journal of the Canadian Association of Gastroenterology|July 12, 2019
The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBDMatthew W Carroll, M Ellen Kuenzig, David R Mack, et al.
Pageof 23